Women with early-stage breast cancer are often treated with adjuvant systemic therapy consisting of chemotherapy, endocrine therapy, agents against human epidermal growth factor receptor 2 (HER2), or combinations of these drugs when appropriate. Treatment decisions are based on characteristics of…
from Cancer via ola Kala on Inoreader http://ift.tt/2bhuRb1
via IFTTT
Τετάρτη 24 Αυγούστου 2016
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου